Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
156,434,424
-
Share change
-
+19,560,196
-
Total reported value
-
$1,451,692,801
-
Put/Call ratio
-
52%
-
Price per share
-
$9.28
-
Number of holders
-
182
-
Value change
-
+$187,013,451
-
Number of buys
-
94
-
Number of sells
-
78
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q2 2025
As of 30 Jun 2025 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 156,434,424 shares of stock of the company.
Largest 10 holders included FMR LLC, Deep Track Capital, LP, Summer Road LLC, VR ADVISER, LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, TCG Crossover Management, LLC, CITADEL ADVISORS LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 182 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.